For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240531:nRSe5498Qa&default-theme=true
RNS Number : 5498Q Oxford Cannabinoid Tech.Holdings 31 May 2024
Oxford Cannabinoid Technologies Holdings plc
("OCT" or the "Company")
Updated Shareholder Engagement following Listing Cancellation
The Board of Oxford Cannabinoid Technologies Holdings plc (LSE:OCTP) refers to
its announcements of 8 May 2024 and 17 May 2024.
On 8 May, the Company said it was exploring the implementation of a Matched
Bargain Facility after the cancellation of listing of its ordinary shares on
the Standard segment of the FCA's Official List and trading on the Main Market
for listed securities of the LSE (Cancellation).
The Board has concluded that it is not practicable in the short term to put in
place such a facility but, following the Cancellation, in the event that there
are any changes to this, details will be made available to shareholders on the
Company's website at www.oxcantech.com (http://www.oxcantech.com)
The Cancellation will become effective at 8.00am on 6 June 2024,
The Directors of the Company accept responsibility for the content of this
announcement.
Enquiries:
Oxford Cannabinoid Technologies Holdings plc +44 (0)20 3034 2820
Clarissa Sowemimo-Coker (CEO) clarissa@oxcantech.com (mailto:clarissa@oxcantech.com)
Hybridan LLP, Financial Adviser and Broker
Claire Louise Noyce +44 (0)20 3764 2341
Acuitas Communications, Financial PR +44 (0)20 3745 0293 / 07799 767676
Simon Nayyar simon.nayyar@acuitascomms.com
Arthur Dingemans arthur.dingemans@acuitascomms.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDEAPSEDFSLEFA
Recent news on Oxford Cannabinoid Technologies Holdings